BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 7669508)

  • 21. Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries.
    Ong P; Athanasiadis A; Borgulya G; Vokshi I; Bastiaenen R; Kubik S; Hill S; Schäufele T; Mahrholdt H; Kaski JC; Sechtem U
    Circulation; 2014 Apr; 129(17):1723-30. PubMed ID: 24573349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should magnesium therapy be considered for the treatment of coronary heart disease? II. Epidemiological evidence in outpatients with and without coronary heart disease.
    Lasserre B; Spoerri M; Moullet V; Theubet MP
    Magnes Res; 1994 Jun; 7(2):145-53. PubMed ID: 7999529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose cyclosporine treatment fails to prevent coronary luminal narrowing after heart transplantation.
    Vassalli G; Kaski JC; Tousoulis D; Kiowski W; Turina M; Follath F; Gallino A
    J Heart Lung Transplant; 1996 Jun; 15(6):612-9. PubMed ID: 8794036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of intra-coronary injection of anisodamine on the slow-reflow phenomenon in patients with acute myocardial infarction after percutaneous coronary intervention].
    Wei YY; Fu XH; Liu J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Apr; 28(4):295-9. PubMed ID: 18543478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Response of coronary arteries to intracoronary acetylcholine infusion in patients with familial hypercholesterolemia].
    Shimizu K; Shimizu M; Sugihara N; Kita Y; Yoshio H; Yamazaki T; Okeie K; Koizumi J; Mabuchi H; Takeda R
    J Cardiol; 1992; 22(2-3):439-46. PubMed ID: 1339802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of hyperoxia and vitamin C on coronary blood flow in patients with ischemic heart disease.
    McNulty PH; Robertson BJ; Tulli MA; Hess J; Harach LA; Scott S; Sinoway LI
    J Appl Physiol (1985); 2007 May; 102(5):2040-5. PubMed ID: 17303710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Detection of stress-induced myocardial ischemia in isolated coronary ectasia and aneurysm (dilatative coronaropathy)].
    Krüger D; Stierle U; Potratz J; Diederich KW; Sheikhzadeh A
    Z Kardiol; 1996 Jun; 85(6):407-17. PubMed ID: 8767365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial ischemia caused by distal coronary-artery constriction in stable angina pectoris.
    Pupita G; Maseri A; Kaski JC; Galassi AR; Gavrielides S; Davies G; Crea F
    N Engl J Med; 1990 Aug; 323(8):514-20. PubMed ID: 2115977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum magnesium-cholesterol relationships in the Central Australian aborigine and in Europeans with and without ischaemic heart disease.
    CHARNOCK JS; CASLEY-SMITH J; SCHWARTZ CJ
    Aust J Exp Biol Med Sci; 1959 Dec; 37():509-16. PubMed ID: 13809346
    [No Abstract]   [Full Text] [Related]  

  • 30. Urinary magnesium excretion as a marker of heart disease risk.
    Larsson SC
    Am J Clin Nutr; 2013 Jun; 97(6):1159-60. PubMed ID: 23615826
    [No Abstract]   [Full Text] [Related]  

  • 31. Variable responses of highly stenotic coronary arteries and collateral circulation to intracoronary injection of nitroglycerin in patients with chronic effort angina.
    Fujita M; Yamanishi K; Miwa K; Inoko M
    Coron Artery Dis; 1994 Jun; 5(6):525-9. PubMed ID: 7952412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active and passive coronary vasodilation after intracoronary and sublingual nitroglycerin.
    Schulz W; von Anderten W; Reiber JH; Bernauer R; Kaltenbach M; Kober G
    Z Kardiol; 1983; 72 Suppl 3():82-6. PubMed ID: 6421018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactivity of coronary arteries in relation to serum magnesium levels in patients with ischaemic heart disease--a quantitative coronary angiographic study.
    Herzog WR; Materese FJ; Atar D
    Magnes Res; 1995 Mar; 8(1):57-63. PubMed ID: 7669508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of intracoronary and intravenous administration of propranolol on coronary vasomotility at rest and during exercise].
    Bortone A; Hess OM; Gaglione A; Locuratolo N; Troito G; Rizzon P; Chiddo A
    Cardiologia; 1989 Aug; 34(8):679-88. PubMed ID: 2605578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronary vasomotion during dynamic exercise: influence of intravenous and intracoronary nicardipine.
    Kaufmann P; Vassalli G; Utzinger U; Hess OM
    J Am Coll Cardiol; 1995 Sep; 26(3):624-31. PubMed ID: 7642851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiographic determination of disease-produced alterations of vasomotor tone in large coronary arteries.
    MacAlpin RN
    Can J Cardiol; 1986 Jul; Suppl A():209A-218A. PubMed ID: 3093035
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.